Carlos Buesa
Carlos Buesa is the CEO of Oryzon Genomics, a biopharmaceutical company focused on developing innovative treatments for psychiatric disorders. Under his leadership, the company has made significant strides in the research and development of new therapies, including Vafidemstat, which shows promise in managing aggression in patients with borderline personality disorder.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Carlos Buesa, the CEO of Oryzon, highlighted the promise of Vafidemstat in controlling agitation and aggression in various CNS disorders.
8